How to Buy Moonlake Immunotherapeutics Stock
Moonlake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation.
Moonlake Immunotherapeutics stock last closed at $13.87, up 0.95% from the previous day, and has decreased 73.67% in one year. It has underperformed other stocks in the Biotechnology industry by 0.39 percentage points. Moonlake Immunotherapeutics stock is currently +133.11% from its 52-week low of $5.95, and -77.9% from its 52-week high of $62.75.
As of Dec 24, 2025, there are 64.23M shares of MLTX outstanding. The market capitalization of MLTX is $890.88M. In the last 24 hours, 536,000 MLTX shares were traded.
How to Buy Moonlake Immunotherapeutics Stock
Wondering how to invest in Moonlake Immunotherapeutics stock? Here's how.
- Figure out where to buy Moonlake Immunotherapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Moonlake Immunotherapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Pick your payment method and add your details.
- Analyze Moonlake Immunotherapeutics stock: The Moonlake Immunotherapeutics ticker symbol is MLTX. Is Moonlake Immunotherapeutics stock a good investment? Should you buy shares of MLTX? How do MLTX's underlying business fundamentals look? Do top analysts think Moonlake Immunotherapeutics is a good buy? Why has MLTX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if MLTX is a good stock to buy).
- Place your MLTX buy order: Decide if you will purchase MLTX shares at the current market price or use a limit order to purchase MLTX shares at a particular price.
- Get the latest news on your MLTX position: Create a watchlist to important notifications about your position in Moonlake Immunotherapeutics stock.
Step 1: Figure out where to buy Moonlake Immunotherapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy MLTX stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to buy MLTX today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've finished signing up on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing funds into your new investment account.
Step 4: Analyze Moonlake Immunotherapeutics stock
After you have chosen the best place to buy Moonlake Immunotherapeutics stock, it's crucial to analyze their stock before you buy, so you can comprehend the risk as well as the upside.
Moonlake Immunotherapeutics Numbers
Moonlake Immunotherapeutics Due Diligence Checks
WallStreetZen was built to help everyday investors perform better fundamental analysis.
You can see all of the due diligence checks on MLTX's stock page.
What is the fair value of MLTX stock?
Investors use many financial metrics, analyses, models, and charts to gauge MLTX's intrinsic value.
Using relative valuations ratios:
- MLTX may be undervalued based on its P/B ratio of 3.08x, relative to Biotechnology industry P/B ratio of 5.43x
You can do additional valuation research on MLTX's stock here.
Is MLTX a healthy company?
Passed Financial Due Diligence Checks:
- Total MLTX debt is lower than 5 years ago, relative to shareholder equity.
- MLTX has cash burn of 185897241. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the MLTX balance sheet.
- There are more short-term assets than long-term liabilities on the MLTX balance sheet.
Failed Financial Due Diligence Checks:
- MLTX has $380.48M in cash and short term investments. This is not enough to cover its annual cash burn of $185.90M.
- MLTX has a relatively high debt to equity ratio of 0.43.
Is it a good time to buy MLTX stock, according to analysts?
Out of 8 sell side analysts who track MLTX, the consensus analyst rating on Moonlake Immunotherapeutics is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent MLTX Analyst Recommendations
Brian Abrahams, a top 14% analyst from RBC Capital downgrades MLTX to a hold rating and lowers their MLTX price target from $67.00 to $10.00, on Sep 29, 2025.
Julian Harrison, a top 4% analyst from BTIG downgrades MLTX to a hold rating and maintains their MLTX price target from $85.00 to $85.00, on Sep 29, 2025.
Richard Law, a top 11% analyst from Goldman Sachs maintains MLTX with a strong buy rating and raises their MLTX price target from $74.00 to $82.00, on Aug 6, 2025.
You can dig deeper into what analysts are projecting on the Moonlake Immunotherapeutics stock forecast page.
Metrics for Advanced MLTX Traders
Who is buying/selling MLTX?
Over the last year, insiders at MLTX have sold more shares than they have bought.
Kristian Reich, Chief Scientific Officer of MLTX, was the latest MLTX insider to sell. They sold $1,052,062.44 worth of MLTX shares on Dec 9, 2025.
Research more about who owns MLTX shares here.
Does MLTX stock generate passive income?
No, Moonlake Immunotherapeutics doesn't provide an income stream by paying out dividends.
What others are saying about MLTX
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your MLTX buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Hit the Open Trade button and your broker will execute your order.
If you require more help with buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your MLTX position
Now that you own some MLTX stock, you'll want to stay up-to-date on your new shares.
Put MLTX on a watchlist to track your MLTX stock.
MLTX Feed
How to Buy Stock in Moonlake Immunotherapeutics
To summarize, here are the 6 steps to buy Moonlake Immunotherapeutics stock:
- Figure out where to buy Moonlake Immunotherapeutics stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Moonlake Immunotherapeutics stock
- Place your MLTX buy order
- Get the latest news on your MLTX position
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your investment in Moonlake Immunotherapeutics, click below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.